Politician Ditches Health Stock, Feels Great

Snack-Sized Version:

Representative Greg Landsman of Ohio dumped shares in UnitedHealth Group along with a smorgasbord of other major companies. He offloaded between $15,001 and $50,000 of UnitedHealth stock from his SARAH LANDSMAN TRADITIONAL IRA account. On the same day, he played financial hopscotch with a flurry of other trades including Visa, Alphabet, and Salesforce. This stock-shedding spree coincided with UnitedHealth’s solid financial performance, including a Q4 earnings beat and a $100.81 billion revenue report. Meanwhile, the healthcare giant’s stock has been flexing with a 52-week range from $436.38 to $630.73 and analysts are still giving it high-fives with strong buy ratings. Institutional investors are piling in like it’s a Black Friday sale, now owning nearly 88% of the company. Between directors scooping up shares and analysts singing praises, UnitedHealth seems to be jogging along just fine—even if a Congressman decided to bow out.

Related Company News

UnitedHealth Group (UNH) Stock Rebounds on Strong Q3

November 18, 2025

UnitedHealth Group (UNH) Falls on Analyst Downgrade

October 31, 2025

UnitedHealth price targets raised to $400 and $433 ahead of Q3 (UNH)

October 17, 2025

Analyze UnitedHealth’s Recent Price Surge

October 14, 2025

Read the Full Meal:

Representative Greg Landsman, a Democrat from Ohio, recently sold a notable chunk of his holdings in UnitedHealth Group. The transaction, disclosed in early April, involved a sale between $15,001 and $50,000 from the SARAH LANDSMAN TRADITIONAL IRA account. Interestingly, this wasn’t an isolated trade. On the same day, March 27th, Landsman seemingly held a Wall Street garage sale, offloading stock in companies like Visa, Salesforce, Alphabet, and CrowdStrike. While his motives remain behind congressional curtains, the volume and breadth of these trades raise an eyebrow or two.

At the time of the sale, UnitedHealth was no slouch. The company had just posted impressive Q4 earnings of $6.81 per share, which beat analyst expectations by $0.07. Revenue for the quarter hit a hefty $100.81 billion, with a 6.8% year-over-year increase. UnitedHealth also recently paid out a quarterly dividend of $2.10 per share, bringing its annual yield to 1.45%. The company boasts a robust return on equity of 26.69%, and its stock performance reflects confidence, with a 52-week high of $630.73.

Meanwhile, institutional investors have been loading up like it’s a buffet line. Major players such as M&T Bank Corp and Sugarloaf Wealth Management significantly increased their stakes. These moves suggest long-term confidence in the healthcare behemoth, even as some insiders tweak their personal portfolios. In fact, Director Timothy Patrick Flynn recently bought 1,000 shares himself—apparently seeing value where others see exits.

Analysts seem to agree with Flynn. Recent upgrades from firms like HSBC, Mizuho, and StockNews.com reinforce a consensus of “Buy” across the board. With price targets ranging up to $700, the outlook for UnitedHealth remains bullish. So while Rep. Landsman might be lightening his financial load, Wall Street seems content to stay buckled in for the ride.